Kermani Tanaz A, Warrington Kenneth J, Dua Anisha B
University of California Los Angeles, 2020 Santa Monica Boulevard, Suite 540, Santa Monica, CA 90404, USA.
Mayo Clinic, 200 First Street Northwest, Rochester, MN 55905, USA.
Rheum Dis Clin North Am. 2022 Aug;48(3):705-724. doi: 10.1016/j.rdc.2022.03.006. Epub 2022 Jul 5.
The vasculitides encompass a group of inflammatory conditions affecting the blood vessels with severe consequences including tissue ischemia, structural abnormalities, such as aneurysms/dissections, and end organ damage. The different forms are commonly classified based on the size of the blood vessel involved as large-vessel, medium-vessel, and small-vessel vasculitis. The American College of Rheumatology/Vasculitis Foundation recently published guidelines on the management of several forms of primary systemic vasculitides. In this review, the recommendations for giant cell arteritis, Takayasu arteritis, polyarteritis nodosa, granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis are discussed. We highlight the key recommendations, aspects where they diverge from other published guidelines, controversies, and areas of uncertainty.
血管炎是一组影响血管的炎症性疾病,会导致严重后果,包括组织缺血、结构异常(如动脉瘤/夹层)和终末器官损害。不同类型的血管炎通常根据受累血管的大小分为大血管、中血管和小血管血管炎。美国风湿病学会/血管炎基金会最近发布了几种原发性系统性血管炎的管理指南。在本综述中,讨论了巨细胞动脉炎、高安动脉炎、结节性多动脉炎、肉芽肿性多血管炎、显微镜下多血管炎和嗜酸性肉芽肿性多血管炎的推荐意见。我们重点介绍了关键推荐意见、它们与其他已发表指南不同的方面、争议点以及存在不确定性的领域。